These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 21842602)

  • 1. [Membranous nephropathy: up to date].
    Imai E
    Nihon Jinzo Gakkai Shi; 2011; 53(5):692-6. PubMed ID: 21842602
    [No Abstract]   [Full Text] [Related]  

  • 2. [Secondary membranous nephropathy].
    Kimura Y; Imai H
    Nihon Jinzo Gakkai Shi; 2011; 53(5):697-702. PubMed ID: 21842603
    [No Abstract]   [Full Text] [Related]  

  • 3. Genes that link nephritis to autoantibodies and innate immunity.
    Segelmark M
    N Engl J Med; 2011 Feb; 364(7):679-80. PubMed ID: 21323547
    [No Abstract]   [Full Text] [Related]  

  • 4. [Pathogenic mechanism of membranous glomerulonephritis obtained from Heymann nephritis and human membranous glomerulonephritis].
    Kamata K
    Nihon Jinzo Gakkai Shi; 2011; 53(5):672-6. PubMed ID: 21842599
    [No Abstract]   [Full Text] [Related]  

  • 5. Risk alleles in idiopathic membranous nephropathy.
    Fernando MM; Vyse TJ
    N Engl J Med; 2011 May; 364(21):2072; author reply 2073-4. PubMed ID: 21612489
    [No Abstract]   [Full Text] [Related]  

  • 6. [Idiopathic and secondary membranous nephropathies].
    Ronco P; Debiec H
    Presse Med; 2012 Mar; 41(3 Pt 1):290-7. PubMed ID: 22208961
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk alleles in idiopathic membranous nephropathy.
    Kiryluk K
    N Engl J Med; 2011 May; 364(21):2072-3; author reply 2073-4. PubMed ID: 21612488
    [No Abstract]   [Full Text] [Related]  

  • 8. Risk alleles in idiopathic membranous nephropathy.
    Pandey JP
    N Engl J Med; 2011 May; 364(21):2073; author reply 2073-4. PubMed ID: 21612487
    [No Abstract]   [Full Text] [Related]  

  • 9. Pathogenesis of membranous nephropathy: recent advances and future challenges.
    Ronco P; Debiec H
    Nat Rev Nephrol; 2012 Feb; 8(4):203-13. PubMed ID: 22371247
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathogenesis of membranous nephropathy: update.
    Kwatra IS; Prasher PK
    J Assoc Physicians India; 2013 Nov; 61(11):807-10. PubMed ID: 24974493
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Membranous nephropathy: the start of a paradigm shift.
    Herrmann SM; Sethi S; Fervenza FC
    Curr Opin Nephrol Hypertens; 2012 Mar; 21(2):203-10. PubMed ID: 22240444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Nephrotic syndrome].
    Masaki T
    Nihon Jinzo Gakkai Shi; 2012; 54(1):35-9. PubMed ID: 22413578
    [No Abstract]   [Full Text] [Related]  

  • 13. Anti-phospholipase A2 receptor antibodies and the pathogenesis of membranous nephropathy.
    Ronco P; Debiec H
    Nephron Clin Pract; 2014; 128(3-4):232-7. PubMed ID: 25401774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coexistence of different circulating anti-podocyte antibodies in membranous nephropathy.
    Murtas C; Bruschi M; Candiano G; Moroni G; Magistroni R; Magnano A; Bruno F; Radice A; Furci L; Argentiero L; Carnevali ML; Messa P; Scolari F; Sinico RA; Gesualdo L; Fervenza FC; Allegri L; Ravani P; Ghiggeri GM
    Clin J Am Soc Nephrol; 2012 Sep; 7(9):1394-400. PubMed ID: 22773590
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk HLA-DQA1 and PLA(2)R1 alleles in idiopathic membranous nephropathy.
    Stanescu HC; Arcos-Burgos M; Medlar A; Bockenhauer D; Kottgen A; Dragomirescu L; Voinescu C; Patel N; Pearce K; Hubank M; Stephens HA; Laundy V; Padmanabhan S; Zawadzka A; Hofstra JM; Coenen MJ; den Heijer M; Kiemeney LA; Bacq-Daian D; Stengel B; Powis SH; Brenchley P; Feehally J; Rees AJ; Debiec H; Wetzels JF; Ronco P; Mathieson PW; Kleta R
    N Engl J Med; 2011 Feb; 364(7):616-26. PubMed ID: 21323541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Membranous nephropathy: A fairy tale for immunopathologists, nephrologists and patients.
    Ronco P; Debiec H
    Mol Immunol; 2015 Nov; 68(1):57-62. PubMed ID: 26597209
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The pathogenesis of membranous nephropathy: evolution and revolution.
    Glassock RJ
    Curr Opin Nephrol Hypertens; 2012 May; 21(3):235-42. PubMed ID: 22388552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-PLA2R antibodies measured by ELISA predict long-term outcome in a prevalent population of patients with idiopathic membranous nephropathy.
    Kanigicherla D; Gummadova J; McKenzie EA; Roberts SA; Harris S; Nikam M; Poulton K; McWilliam L; Short CD; Venning M; Brenchley PE
    Kidney Int; 2013 May; 83(5):940-8. PubMed ID: 23364522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antigen identification in membranous nephropathy moves toward targeted monitoring and new therapy.
    Ronco P; Debiec H
    J Am Soc Nephrol; 2010 Apr; 21(4):564-9. PubMed ID: 20185638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Anti-NEP and anti-PLA2R antibodies in membranous nephropathy: an update].
    Pozdzik AA; Debiec H; I Brochériou ; Husson C; Rorive S; Broeders N; Le Moine A; Ronco P; Nortier J
    Rev Med Brux; 2015; 36(3):166-71. PubMed ID: 26372979
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.